PROVIDER PROFILE · NPI 1831318583
Jazibeh QureshiM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,885
Unique beneficiaries
—
Total services
113,303
Distinct HCPCS
19
Medicare payment
$1.3M
Peer benchmark
Total Medicare services vs. 133 Rheumatology providers in MD — top quintile (cohort median 27,542).
PRESCRIBING · PART D · 2024
Total Rx claims
2,428
Beneficiaries
—
Total drug cost
$2.1M
Distinct drugs
34
Brand share
27.3%
Top prescribed drugs
Hydroxychloroquine Sulfate390 claims
Methotrexate Sodium348 claims
Duloxetine Hcl220 claims
Gabapentin175 claims
Prednisone142 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
172
By payment type
Food and Beverage$4K
Education$62
Top paying entities
Food and Beverage$4K
Education$62
REFERRAL NETWORK
Where Jazibeh Qureshi's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 15 | 29 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE